26/07/2016 21:13:26 1-888-992-3836 (toll free) Free Membership Login

Parexel News (NASDAQ:PRXL)

DateTimeSource
Headline
07/11/20169:00AMBWPAREXEL International Announces Date of Fourth Quarter and Fiscal Year 2016 Earnings Release and Conference Call
PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for Fourth Quarter and Fiscal Year 2016 on Wednesday, August 3, 2016 after the close of the stock market. PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, August 4, 2016, to discuss the results. To access the... More...>>
06/30/20168:00AMBWPAREXEL International Outlines Growth Strategy and Updates Financial Guidance at Investor Day
10–18% diluted EPS growth expected in Fiscal Year 2017*, driven by continued revenue growth and margin improvement Long-term target range for adjusted operating margin increased to 14–16% Long-term target of double-digit revenue and adjusted diluted EPS growth PAREXEL’s growth strategy built on focus on its core... More...>>
06/20/20169:00AMBWPAREXEL Experts to Discuss Key Drug Development Insights at DIA 2016
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that several of its experts will discuss key issues facing the industry at the 52nd Annual Drug Information Association (DIA) meeting, held from June 26-30, 2016 in Philadelphia. PAREXEL will hold in-booth... More...>>
06/15/20169:00AMBWPAREXEL Invites Public to Listen to Live Webcast of Investor Day Presentations on June 30
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day presentations on Thursday, June 30, 2016, from 9:00 a.m. to 12:00 p.m. EDT. All interested parties are invited to listen as Chairman and Chief Executive... More...>>
06/10/20162:00AMBWPAREXEL Announces Master Services Agreement with Pfizer
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has signed a services agreement with Pfizer Inc. Under the terms of this agreement, PAREXEL will continue to provide global clinical research and development services to Pfizer in support of clinical... More...>>
06/02/20169:00AMBWPAREXEL Named Company of the Year for the Pharmaceuticals Industry with a Gold Stevie from the American Business Awards
Company also awarded Gold Stevie Award for Best Public Relations Event PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, has been named Company of the Year – Pharmaceuticals in the 14th Annual American Business AwardsSM. The judges awarded PAREXEL a Gold Stevie®... More...>>
05/24/20169:00AMBWPAREXEL International to Present at Goldman Sachs Global Healthcare Conference and Jefferies Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that executives will be making a presentation on PAREXEL and discussing business developments and financial outlook at two investor conferences in June. Ingo Bank, Senior Vice President and Chief Financial Officer, will present at the Goldman Sachs Global... More...>>
05/09/20169:00AMBWPAREXEL International to Present at UBS Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the UBS Healthcare Conference on Tuesday, May 24, 2016, in New York City. Ingo Bank, Senior Vice President and Chief Financial Officer will be making a presentation on PAREXEL and discussing business developments at 8:30 a.m... More...>>
04/27/20164:01PMBWPAREXEL International Reports Third Quarter Fiscal Year 2016 Results
Adjusted earnings per share of $0.89, up 34.8%; GAAP diluted earnings per share of $0.89, up 30.9% Adjusted operating margin of 13.3%; GAAP operating margin of 13.2% Gross new business wins of $999 million; net book-to-bill ratio of 1.33; backlog at $5.7 billion Service revenue of $527.1 million, up 5.0%; constant currency... More...>>
04/21/20162:00PMBWPAREXEL International to Present at Deutsche Bank Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will present at the Deutsche Bank 41st Annual Health Care Conference in Boston. Mr. Josef von Rickenbach, Chairman and CEO, will make a presentation on PAREXEL’s business activities and financial outlook at 12:50 p.m. Wednesday, May 4, 2016. A live... More...>>
04/13/20169:00AMBWPAREXEL and EMC Form Alliance to Provide Cloud-Based Document and Regulatory Information Management Services
PAREXEL enhances its Regulatory Cloud; leverages EMC® Documentum® for Life Sciences software solution suite to offer an end-to-end regulatory solution PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, and EMC Corporation (NYSE: EMC) today announced they have entered... More...>>
03/24/20164:00PMBWPAREXEL International Announces Date of Third Quarter Fiscal Year 2016 Earnings Release and Conference Call
PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter Fiscal Year 2016 on Wednesday, April 27th, 2016 after the close of the stock market. PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, April 28th, 2016 to discuss the results. To access... More...>>
03/23/20162:40PMBWPAREXEL Named to the 2016 Forbes America’s Best Employers List
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that Forbes named the Company to the magazine’s America’s “Best Employers” list for 2016. The list features the top 500 U.S. employers with more than 5,000 employees as rated by 30,000 employees... More...>>
03/03/20169:00AMBWPAREXEL International to Present at Barclay’s Global Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Barclay’s Global Healthcare Conference on Thursday, March 17, 2016, in Miami. Ingo Bank, Senior Vice President and Chief Financial Officer will be making a presentation on PAREXEL and discussing business developments at... More...>>
02/29/20169:00AMBWParexel Named a FlexJobs Top 100 Company to Watch for Telecommuting Jobs in 2016
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has been named to the FlexJobs Top 100 Companies to Watch for Telecommuting Jobs in 2016 for the third consecutive year. The list recognizes companies with a telecommuting-friendly component... More...>>
02/17/20169:00AMBWPAREXEL Launches Expanded Genomic Research Services
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced expanded services and capabilities in genomic-based drug development. The PAREXEL® Genomic Medicine team offers clients a variety of strategic and operational genomic research services to accelerate... More...>>
01/27/20164:05PMBWPAREXEL International Reports Second Quarter Fiscal Year 2016 Results
Adjusted earnings per share of $0.90, up 30.4%; GAAP diluted earnings per share of $0.73 Adjusted operating margin of 13.2%; GAAP operating margin of 10.5% Gross new business wins of $867 million; net book-to-bill ratio of 1.24; backlog at $5.5 billion Service revenue of $518.5 million, up 3.8%; constant currency revenue... More...>>
01/21/20169:30AMBWOptum & PAREXEL to Accelerate Drug Development, Reimbursement & Market Access with EHR-Fueled Clinical Research & Hybrid Stud...
Collaboration will focus on advancing drug development by combining clinical research and real-world evidence Optum and PAREXEL International (NASDAQ:PRXL) formed a strategic alliance to reduce drug development costs associated with post-approval studies, which are conducted after the approval of a product to obtain further... More...>>
01/19/201612:00PMBWPAREXEL Announces Execution of Definitive Agreement to Acquire Health Advances
Acquisition will strengthen PAREXEL’s Leadership in Strategic Consulting Services PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that the Company has entered into a definitive agreement to acquire all outstanding equity securities of Health... More...>>
01/04/20169:00AMBWPAREXEL International to Present at JP Morgan Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the JP Morgan Healthcare Conference on Wednesday, January 13, 2016, in San Francisco. Ingo Bank, Senior Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V:us D:20160727 01:13:26